Document is current
Any future updates will be listed below
-
Authors
Larsson, Peter
Pettersson, Daniella
Engqvist, Hanna
Werner Rönnerman, Elisabeth
Forssell-Aronsson, Eva
Kovács, Anikó
Karlsson, Per
Helou, Khalil
Parris, Toshima Z.
-
Funding
Funding for this research was provided by:
Stiftelsen Assar Gabrielssons Fond (FB19-04)
Cancerfonden (CAN2018/471)
Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer (2020:295)
The Swedish Society of Medicine (SLS-935552)
University of Gothenburg
- License Information
-
More Information
Article History
Received: 14 January 2021
Accepted: 5 September 2022
First Online: 19 September 2022
Declarations
:
: For the present study, only genomic and transcriptomic data for the breast cancer validation cohort from our previous study were used [CitationRef removed]. All procedures using breast cancer tissue samples retrieved from the fresh-frozen tissue tumor bank at the Sahlgrenska University Hospital Oncology Lab (Gothenburg, Sweden) were done in accordance with the Declaration of Helsinki and approved by the Medical Faculty Research Ethics Committee (Gothenburg, Sweden; application number S164-02). Due to the retrospective study design and deidentification of the patient material, the Medical Faculty Research Ethics Committee approved a waiver of written informed consent to use the breast tumor specimens.
: Not applicable.
: The author declares that they have no competing interests.
